GGrantIndex
← Leaderboards

Bin Zheng

Cedars-Sinai Medical Center

$7,982,696
Attributed
$10,967,817
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY200825
$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,967,817 · 8

By mechanism

R01$9,591,424 · 5
R00$732,060 · 1
R21$380,513 · 1
K99$263,820 · 1

Top collaborators

Most similar at Cedars-Sinai Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Tumor

Research focus

TumorPathway InteractionsMelanomaRegulationSignal TransductionBraf GeneMalignant NeoplasmsMutantMutateMelanoma CellResponseMolecularSignal PathwayCellsTumor Suppressor ProteinsMeksMouse ModelResistanceIn VitroMutationCancer CellBaseOncogenic5&Apos

Grant awards (29)

Regulation of interferon signaling in melanoma by the cohesin complex protein STAG2 via 3D genome organization$764,025
R01 · FY2025 · CA · contact PI
Role of AMPK in melanoma brain metastasis$671,615
R01 · FY2025 · CA · contact PI
Metabolic regulation of immunosuppressive myeloid cells in the tumor microenvironment of pancreatic cancer.$667,601
R01 · FY2025 · CA
Metabolic regulation of immunosuppressive myeloid cells in the tumor microenvironment of pancreatic cancer.$681,198
R01 · FY2024 · CA
Role of AMPK in melanoma brain metastasis$637,432
R01 · FY2024 · CA · contact PI
Regulation of interferon signaling in melanoma by the cohesin complex protein STAG2 via 3D genome organization$362,913
R01 · FY2024 · CA · contact PI
Targeting Hippo pathway in melanoma$518,652
R01 · FY2023 · CA
Role of AMPK in melanoma brain metastasis$499,166
R01 · FY2023 · CA · contact PI
Regulation of interferon signaling in melanoma by the cohesin complex protein STAG2 via 3D genome organization$374,372
R01 · FY2023 · CA · contact PI
Role of AMPK in melanoma brain metastasis$188,216
R01 · FY2023 · CA · contact PI
Targeting Hippo pathway in melanoma$518,652
R01 · FY2022 · CA
Regulation of interferon signaling in melanoma by the cohesin complex protein STAG2 via 3D genome organization$374,626
R01 · FY2022 · CA · contact PI
Targeting Hippo pathway in melanoma$529,237
R01 · FY2021 · CA
Targeting Hippo pathway in melanoma$529,237
R01 · FY2020 · CA
Target metabolic vulnerabilities of MDSCs to enhance cancer immunotherapy$171,932
R21 · FY2020 · CA · contact PI
Targeting Hippo pathway in melanoma$529,237
R01 · FY2019 · CA
Target metabolic vulnerabilities of MDSCs to enhance cancer immunotherapy$208,581
R21 · FY2019 · CA · contact PI
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation$75,000
R01 · FY2018 · CA · contact PI
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation$345,510
R01 · FY2016 · CA · contact PI
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation$345,510
R01 · FY2015 · CA · contact PI
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation$335,145
R01 · FY2014 · CA · contact PI
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation$281,243
R01 · FY2013 · CA · contact PI
Targeting the LKB1-AMPK PATHWAY in Melanoma: Mechanism and Preclinical Evaluation$30,837
R01 · FY2013 · CA · contact PI
Targeting the LKB1-AMPK PATHWAY in Melanoma: Mechanism and Preclinical Evaluation$332,000
R01 · FY2012 · CA · contact PI
Regulation of LKB1 and AMPK Signaling by BRAF in Melanoma$241,530
R00 · FY2012 · CA · contact PI
Regulation of LKB1 and AMPK Signaling by BRAF in Melanoma$241,530
R00 · FY2011 · CA · contact PI
Regulation of LKB1 and AMPK Signaling by BRAF in Melanoma$249,000
R00 · FY2010 · CA · contact PI
Regulation of LKB1 and AMPK Signaling by BRAF in Melanoma$132,030
K99 · FY2009 · CA · contact PI
Regulation of LKB1 and AMPK Signaling by BRAF in Melanoma$131,790
K99 · FY2008 · CA · contact PI